CML的TKI治疗机制及副作用
CML 研究和治疗的里程碑
1. Silver RT, et al. Blood 1999;94:1517–362. Baccarani M, et al. Blood 2006;108:1809–203. Baccarani M, et al. J Clin Oncol 2009;27:6041–51
ASH = American Society of HematologyBMT = bone marrow transplant
ELN = European LeukemiaNet; IFN = interferon
酪氨酸激酶抑制剂(TKI)治疗CML